NEXUS AG (NXU.DE) Stock Fundamental Analysis
FRA:NXU - Deutsche Boerse Ag - DE0005220909 - Common Stock - Currency: EUR
Taking everything into account, NXU scores 6 out of 10 in our fundamental rating. NXU was compared to 10 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making NXU a very profitable company, without any liquidiy or solvency issues. NXU is valued quite expensive, but it does show an excellent growth. With these ratings, NXU could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year NXU was profitable.
NXU had a positive operating cash flow in the past year.
NXU had positive earnings in each of the past 5 years.
NXU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
NXU has a Return On Assets of 6.82%. This is comparable to the rest of the industry: NXU outperforms 50.00% of its industry peers.
With a Return On Equity value of 11.31%, NXU perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Return On Invested Capital of NXU (8.78%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for NXU is in line with the industry average of 9.32%.
The 3 year average ROIC (7.85%) for NXU is below the current ROIC(8.78%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.82% | ||
| ROE | 11.31% | ||
| ROIC | 8.78% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
1.3 Margins
With a decent Profit Margin value of 12.10%, NXU is doing good in the industry, outperforming 70.00% of the companies in the same industry.
NXU's Profit Margin has improved in the last couple of years.
NXU has a Operating Margin of 15.58%. This is in the better half of the industry: NXU outperforms 80.00% of its industry peers.
NXU's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 85.51%, NXU is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
NXU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.58% | ||
| PM (TTM) | 12.1% | ||
| GM | 85.51% |
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NXU is creating some value.
Compared to 1 year ago, NXU has about the same amount of shares outstanding.
Compared to 5 years ago, NXU has more shares outstanding
NXU has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.52 indicates that NXU is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.52, NXU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Debt to FCF ratio of NXU is 0.41, which is an excellent value as it means it would take NXU, only 0.41 years of fcf income to pay off all of its debts.
NXU has a Debt to FCF ratio of 0.41. This is in the better half of the industry: NXU outperforms 80.00% of its industry peers.
NXU has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.05, NXU is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.41 | ||
| Altman-Z | 5.52 |
ROIC/WACC1.23
WACC7.11%
2.3 Liquidity
A Current Ratio of 1.93 indicates that NXU should not have too much problems paying its short term obligations.
The Current ratio of NXU (1.93) is better than 70.00% of its industry peers.
NXU has a Quick Ratio of 1.89. This is a normal value and indicates that NXU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.89, NXU is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.89 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 30.35% over the past year.
Measured over the past years, NXU shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.97% on average per year.
Looking at the last year, NXU shows a small growth in Revenue. The Revenue has grown by 7.65% in the last year.
The Revenue has been growing by 12.11% on average over the past years. This is quite good.
EPS 1Y (TTM)30.35%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%25.55%
Revenue 1Y (TTM)7.65%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%11.17%
3.2 Future
NXU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.50% yearly.
NXU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.47% yearly.
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
NXU is valuated quite expensively with a Price/Earnings ratio of 37.66.
Compared to the rest of the industry, the Price/Earnings ratio of NXU is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.48, NXU is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 32.06, the valuation of NXU can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as NXU.
NXU is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 34.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.66 | ||
| Fwd PE | 32.06 |
4.2 Price Multiples
NXU's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. NXU is more expensive than 60.00% of the companies in the same industry.
NXU's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.55 | ||
| EV/EBITDA | 16.07 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
NXU has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as NXU's earnings are expected to grow with 15.50% in the coming years.
PEG (NY)2.58
PEG (5Y)1.8
EPS Next 2Y14.95%
EPS Next 3Y15.5%
5. Dividend
5.1 Amount
NXU has a yearly dividend return of 0.32%, which is pretty low.
Compared to an average industry Dividend Yield of 3.39, NXU has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, NXU's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
5.2 History
The dividend of NXU has a limited annual growth rate of 2.17%.
Dividend Growth(5Y)2.17%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
NXU pays out 11.69% of its income as dividend. This is a sustainable payout ratio.
NXU's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP11.69%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
FRA:NXU (8/8/2025, 7:00:00 PM)
70.8
-0.4 (-0.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners55.8%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.22B
Analysts45.71
Price Target70.76 (-0.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
Yearly Dividend0.22
Dividend Growth(5Y)2.17%
DP11.69%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.66 | ||
| Fwd PE | 32.06 | ||
| P/S | 4.55 | ||
| P/FCF | 24.55 | ||
| P/OCF | 20.31 | ||
| P/B | 4.26 | ||
| P/tB | 15.33 | ||
| EV/EBITDA | 16.07 |
EPS(TTM)1.88
EY2.66%
EPS(NY)2.21
Fwd EY3.12%
FCF(TTM)2.88
FCFY4.07%
OCF(TTM)3.49
OCFY4.92%
SpS15.55
BVpS16.63
TBVpS4.62
PEG (NY)2.58
PEG (5Y)1.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.82% | ||
| ROE | 11.31% | ||
| ROCE | 11.71% | ||
| ROIC | 8.78% | ||
| ROICexc | 15.25% | ||
| ROICexgc | N/A | ||
| OM | 15.58% | ||
| PM (TTM) | 12.1% | ||
| GM | 85.51% | ||
| FCFM | 18.55% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
ROICexc(3y)12.19%
ROICexc(5y)11.45%
ROICexgc(3y)147.03%
ROICexgc(5y)150.84%
ROCE(3y)10.47%
ROCE(5y)10.94%
ROICexcg growth 3Y-0.23%
ROICexcg growth 5Y4.33%
ROICexc growth 3Y3.77%
ROICexc growth 5Y2.6%
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.41 | ||
| Debt/EBITDA | 0.25 | ||
| Cap/Depr | 54.49% | ||
| Cap/Sales | 3.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 98.85% | ||
| Profit Quality | 153.36% | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.89 | ||
| Altman-Z | 5.52 |
F-Score8
WACC7.11%
ROIC/WACC1.23
Cap/Depr(3y)46.55%
Cap/Depr(5y)41.01%
Cap/Sales(3y)3.52%
Cap/Sales(5y)3.36%
Profit Quality(3y)122.34%
Profit Quality(5y)137.83%
High Growth Momentum
Growth
EPS 1Y (TTM)30.35%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%25.55%
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.65%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%11.17%
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
EBIT growth 1Y27.31%
EBIT growth 3Y16.4%
EBIT growth 5Y15.93%
EBIT Next Year66.24%
EBIT Next 3Y29.63%
EBIT Next 5YN/A
FCF growth 1Y122.1%
FCF growth 3Y16.82%
FCF growth 5Y17.03%
OCF growth 1Y112.34%
OCF growth 3Y17.98%
OCF growth 5Y15.93%